HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses.

Abstract
Platelet factor 3 (PF3) was assayed by Russell's viper venom (RVV) in three plasma fractions, platelet-rich plasma (PRP), platelet poor plasma (PPP), and 0.1 microns particle-filtered plasma (PFP), in 42 healthy controls, 34 patients with recent cerebrovascular accidents (CVA) and 28 with recent ischemic events from coronary artery disease (CAD). Platelet microparticles (PMP) were assayed in PPP by flow cytometry. Relative to controls, the RVV clotting times were shortened in all three plasma fractions in both patient groups, p < 0.001. PMP were also elevated in both patient groups, p < 0.001. Linear regression analysis showed that the RVV times of PPP are inversely correlated with PMP, p < 0.005, in patient groups but not in controls. There was no correlation of RVV time with PT, APTT or FIB. After converting RVV times to units of PF3 activity, it could be shown that only about 1/4 of the total PF3 activity was contributed by platelets. The major contribution to the PF3 activity in controls was from microparticles < 0.1 microns but in patients was due mainly to microparticles > 0.1 microns. The RVV time was superior to routine coagulation tests in discriminating thrombotic patients from healthy controls.
AuthorsW Jy, L L Horstman, F Wang, R C Duncan, Y S Ahn
JournalThrombosis research (Thromb Res) Vol. 80 Issue 6 Pg. 471-82 (Dec 15 1995) ISSN: 0049-3848 [Print] United States
PMID8610275 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Coagulants
  • Platelet Factor 3
Topics
  • Adolescent
  • Adult
  • Aged
  • Coagulants (metabolism)
  • Female
  • Flow Cytometry
  • Humans
  • Male
  • Middle Aged
  • Particle Size
  • Plasma (metabolism)
  • Platelet Factor 3 (metabolism)
  • Prothrombin Time
  • Regression Analysis
  • Risk Factors
  • Thrombosis (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: